These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32351772)

  • 41. Clinical and molecular features of type 1 pseudohypoaldosteronism.
    Riepe FG
    Horm Res; 2009; 72(1):1-9. PubMed ID: 19571553
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Primary hypoaldosteronism, pseudo-hypoaldosteronism and distal tubular acidosis].
    Klaus D
    Klin Wochenschr; 1984 Aug; 62(16):747-52. PubMed ID: 6384650
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Multiple type I pseudohypoaldosteronism: neonatal management and outcome].
    Cristina De Frutos Martínez M; Elorza Martínez M; Salas Hernández S; García Sánchez P; Jaso Cortés E; Pérez-Rodríguez J; Quero Jiménez J
    An Esp Pediatr; 2000 Jan; 52(1):47-51. PubMed ID: 11003859
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel mutation of the epithelial Na+ channel causes type 1 pseudohypoaldosteronism.
    Bonny O; Knoers N; Monnens L; Rossier BC
    Pediatr Nephrol; 2002 Oct; 17(10):804-8. PubMed ID: 12376807
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pseudohypoaldosteronism presenting as acute gastroenteritis: report of one case.
    Yu MC; Hou JW
    Acta Paediatr Taiwan; 2003; 44(1):44-6. PubMed ID: 12800385
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Autosomal Dominant Pseudohypoaldosteronism Type 1 in a Newborn With Failure to Thrive.
    Krishna S; Augustian M
    Cureus; 2024 Apr; 16(4):e59356. PubMed ID: 38689677
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Revealing a subclinical salt-losing phenotype in heterozygous carriers of the novel S562P mutation in the alpha subunit of the epithelial sodium channel.
    Riepe FG; van Bemmelen MX; Cachat F; Plendl H; Gautschi I; Krone N; Holterhus PM; Theintz G; Schild L
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):252-8. PubMed ID: 18547339
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pseudohypoaldosteronism Type 1B and Cohen Syndrome: Novel Mutation, Unusual Combination, and Presentation.
    Alsaleh Y; Al Ghadeer HA; Aljabri A; Alhashim Z; Mohamed M; Busaleh F; Alramadhan FA; Alghazal MM
    Cureus; 2024 Mar; 16(3):e57217. PubMed ID: 38681476
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Case report: severe neonatal hyperkalemia due to pseudohypoaldosteronism type 1.
    Schweiger B; Moriarty MW; Cadnapaphornchai MA
    Curr Opin Pediatr; 2009 Apr; 21(2):269-71. PubMed ID: 19657313
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel missense mutation of mineralocorticoid receptor gene in one Japanese family with a renal form of pseudohypoaldosteronism type 1.
    Tajima T; Kitagawa H; Yokoya S; Tachibana K; Adachi M; Nakae J; Suwa S; Katoh S; Fujieda K
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4690-4. PubMed ID: 11134129
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pseudohypoaldosteronism Type 1: The Presentation and Management of a Neonate With a Novel Mutation of the SCNN1B Gene Found in Two Hispanic Siblings.
    Pugh CP
    Cureus; 2022 Apr; 14(4):e23918. PubMed ID: 35530903
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Secondary Pseudohypoaldosteronism Associated With Mild Hydronephrosis in a Newborn.
    Kodo K; Goto S; Katsumi Y
    Cureus; 2021 Feb; 13(2):e13462. PubMed ID: 33777551
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Abnormalities of aldosterone synthesis and action in children.
    White PC
    Curr Opin Pediatr; 1997 Aug; 9(4):424-30. PubMed ID: 9300202
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Novel
    Huneif MA; Alhazmy ZH; Shoomi AM; Alghofely MA; Heena H; Mushiba AM; AlSaheel A
    J Clin Res Pediatr Endocrinol; 2022 Jun; 14(2):244-250. PubMed ID: 33829730
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hook effect: a pitfall leading to misdiagnosis of hypoaldosteronism in an infant with pseudohypoaldosteronism.
    Akin L; Kurtoglu S; Kendirci M; Akin MA; Hartmann MF; Wudy SA
    Horm Res Paediatr; 2010; 74(1):72-5. PubMed ID: 20431271
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A homozygous missense mutation in SCNN1A is responsible for a transient neonatal form of pseudohypoaldosteronism type 1.
    Dirlewanger M; Huser D; Zennaro MC; Girardin E; Schild L; Schwitzgebel VM
    Am J Physiol Endocrinol Metab; 2011 Sep; 301(3):E467-73. PubMed ID: 21653223
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Severe hyperkalemia is rescued by low-potassium diet in renal βENaC-deficient mice.
    Boscardin E; Perrier R; Sergi C; Maillard M; Loffing J; Loffing-Cueni D; Koesters R; Rossier BC; Hummler E
    Pflugers Arch; 2017 Oct; 469(10):1387-1399. PubMed ID: 28567665
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pseudohypoaldosteronism types I and II: little more than a name in common.
    Casas-Alba D; Vila Cots J; Monfort Carretero L; Martorell Sampol L; Zennaro MC; Jeunemaitre X; Camacho Díaz JA
    J Pediatr Endocrinol Metab; 2017 May; 30(5):597-601. PubMed ID: 28593901
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Splicing mutation in CYP21 associated with delayed presentation of salt-wasting congenital adrenal hyperplasia.
    Kohn B; Day D; Alemzadeh R; Enerio D; Patel SV; Pelczar JV; Speiser PW
    Am J Med Genet; 1995 Jul; 57(3):450-4. PubMed ID: 7677150
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Salt losing nephropathy simulating congenital adrenal hyperplasia in an infant.
    Kari JA; Bamashmous HA; Al-Agha AE; Mosli HA
    Saudi Med J; 2002 Jul; 23(7):863-5. PubMed ID: 12174243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.